Mechanism of action of Huangbaichen Sanwei formulation in treating T2DM based on network pharmacology and molecular docking

Huangbaichen Sanwei formulation (HBCS) has been reported to have a good hypoglycemic effect, but its pharmacological mechanism of action remains unclear. We used network pharmacology and molecular docking to explore the potential mechanism of action of HBCS against type-2 diabetes mellitus (T2DM). F...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunnan, Shen, Jiaming, Jing, Xiaolong, Zhang, Kaiyue, Liu, Lu, Wang, Yuelong, Zhang, Hui, Sun, Jiaming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659618/
https://www.ncbi.nlm.nih.gov/pubmed/37986298
http://dx.doi.org/10.1097/MD.0000000000036146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659618/
https://www.ncbi.nlm.nih.gov/pubmed/37986298
http://dx.doi.org/10.1097/MD.0000000000036146

Ejemplares similares